Раздел 1.1

1.           И.В. Булычева, А.В. Федорова, M.J. Klein, Ю.Н. Соловьев. Атлас ортопедической патологии. Том 1. Хрящеобразующие опухоли, 2021.
2.           Milch R.A., Changus G.W. Response of bone to tumor invasion. Cancer. 1956; 9:340–351.
3.           Spjut H.J., Dorfman H.D., Fechner R.E., et al. Tumors of bone and cartilage. In: Atlas of Tumor Pathology, Fascicle 5, Series 2. Armed Forces Institute of Pathology; Washington, DC: 1971.
4.           Greenspan A., Klein M.J. Radiology and pathology of bone tumors. In: Musculoskeletal Oncology: An Interdisciplinary Approach. Philadelphia, PA: WB Saunders Co.; 1992:13–72.
5.           Madewell J.E., Ragsdale B.D., Sweet D.E. Radiologic and pathologic analysis of solitary bone lesions. Part I. Internal margins. Radiol Clin North Am. 1981; 19:715–748.
6.           Lodwick G.S., Wilson A.J., Farrell C., et al. Determining growth rates of focal lesions of bone from radiographs. Radiology. 1980; 134:577.
7.           Milch R.A., Changus G.W. Response of bone to tumor invasion. Cancer. 1956; 9:340–351.
8.           Greenspan A., Klein M.J. Radiology and pathology of bone tumors. In: Musculoskeletal Oncology: An Interdisciplinary Approach. Philadelphia, PA: WB Saunders Co.; 1992:13–72.
9.           Ragsdale B.D., Madewell J.E. , Sweet D.E. Radiologic and pathologic analysis of solitary bone lesions. Part II: Periosteal reactions. Radiol Clin North Am. 1981; 19:749–783.
10.        Kahn L.B., Wood F.W., Ackerman L.V. Fracture callus associated with benign and malignant bone lesions and mimicking osteosarcoma. Am J Clin Pathol. 1969; 52:14.
11.        Sprawls Perry. The Physical Principles of Diagnostic Imaging. Baltimore, MD: University Park Press, 1993. 656 p.
12.        WebbA. Introduction to Biomedical Imaging. Piscataway, NJ: IEEE Press-Wiley Interscience; 2003.
13.        Olendorf W., Olendorf W. Jr. MRI Primer. New York, NY: Raven Press; 1991.
14.        Gilkey F., Sweet D.E., Mirra J. Radiologic. pathologic correlation of bone tumors. In: Mirra J, ed. Bone Tumors, Clinical, Radiologic, and Pathologic Correlations. 2nd ed. Chapter 27. JB Lippincott Co.: Philadelphia, PA; 1989:1803–1831.
15.        McLeod R.A., Berquist T.H. Bone tumor imaging: contribution of CT and MRI. In: Unni KK, ed. Bone Tumors. New York, NY: Churchill Livingstone; 1988:1–34.
16.        Hayes C. Assessing changes in tumor vascular function using dynamic contrast-enhanced magnetic resonance imaging/ Hayes C., Padhani A.R., Leach M.O. et al.// NMR Biomed. 2002.№15. Р.154-163.
17.        O’Sullivan G.J., Carty F.L., Cronin C.G. Imaging of bone metastasis: An update. World J Radiol 2015; 7:202-11.
18.        Johansson L., Wehling M. Translational imaging research. In: Principles of Translational Science in Medicine. 2nd ed., Ch. 3.7.3. Boston, MA: Academic Press; 2015. P. 189-194.
19.        Adams C., Banks K.P. Bone scan. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih. gov/books/NBK531486/. [Last updated on 2022 Aug 08.
20.        Lu F.M., Yuan Z. PET/SPECT molecular imaging in clinical neuroscience: Recent advances in the investigation of CNS diseases. Quant Imaging Med Surg 2015; 5:433-47.
21.        Shukla A.K., Kumar U. Positron emission tomography: An overview. J Med Phys 2006; 31:13-21.
22.        Cook G.J., Goh V. Functional and hybrid imaging of bone metastases. J Bone Miner Res 2018;33:961-72.
23.        Heindel W., Gübitz R., Vieth V., Weckesser M., Schober O., Schäfers M. The diagnostic imaging of bone metastases. Dtsch Arztebl Int 2014;111:741-7.
24.        Chaudhuri T.K. The “hot” spot in bone imaging. Semin Nucl Med 1983;13:75-7.
25.        Ghosh P. The role of SPECT/CT in skeletal malignancies. Semin Musculoskelet Radiol 2014;18:175-93.
26.        Shen G., Deng H., Hu S., Jia Z. Comparison of choline PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: A meta-analysis. Skeletal Radiol 2014; 43:1503-13.
27.        Yandrapalli S., Puckett Y. SPECT imaging. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK564426/. [Last updated on 2022 Oct 03]
28.        Cook G.J., Houston S., Rubens R., Maisey M.N., Fogelman I. Detection of bone metastases in breast cancer by 18FDG PET: Differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 1998; 16:3375-9.
29.        Ahlawat S., Debs P., Amini B., Lecouvet F.E., Omoumi P., Wessell D.E. Clinical applications and controversies of whole-body MRI: AJR expert panel narrative review. Am J Roentgenol. 2023; 220(4):463–75.
30.        Cruz I.A.N., Fayad L.M., Ahlawat S. et al. Whole-body MRI in musculoskeletal oncology: a comprehensive review with recommendations. Radiol Imaging Cancer. 2023; 5(3): e220107.
31.        Rama S., Suh C.H., Kim K.W., Durieux J.C., Ramaiya N.H., Tirumani S.H. Comparative performance of whole-body MRI and FDG PET/CT in evaluation of multiple myeloma treatment response: systematic review and meta-analysis. AJR Am J Roentgenol. 2022;218(4):602-13.
32.        Shortt C.P., Gleeson T.G., Breen K.A., et al. Whole-body MRI versus PET in assessment of multiple myeloma disease activity. Am J Roentgenol. 2009;192(4):980-6.
33.        Zhan Y., Zhang G., Li M., Zhou X. Whole-body MRI vs. PET/CT for the detection of bone metastases in patients with prostate cancer: a systematic review and meta-analysis. Front Oncol. 2021; 11:633833.
34.        Behzadi A.H., Raza S.I., Carrino J.A., et al. Applications of PET/CT and PET/MR imaging in primary bone malignancies. PET Clin. 2018;13(4):623-34.
35.        Shojaie P., Afzali M., Nischal N., Iyengar K.P., Yousef M.M.A., Botchu R. Bone tumor imaging: an update on modalities and radiological fndings. J Arthrosc Joint Surg. 2023;10(3):131
36.        WHO Classification of Tumors of Soft Tissue and Bone. International Agency for Research on Cancer, Lyon, 2013.
37.        Jaffe H.L. Tumors and Tumorous Diseases of Bones and Joints. New York, NY: Lea and Febiger; 1958.
38.        Connie Y. Chang et al, Society of Skeletal Radiology-white paper. Guidelines for the diagnostic management of incidental solitary bone lesions on CT and MRI in adults: bone reporting and data system (Bone-RADS)/ Skeletal Radiol 2022. Sep.; 51(9):1743-1764.
39.        Jamie T. Caracciolo, MD, MBA et al. Bone Tumor Risk Stratification and Management System: A Consensus Guideline from the ACR Bone Reporting and Data System Committee, JACR Volume 20, Issue 10p1044-1058. October.
40.        Булычева И.В., Семенова Л.А. Внутрисуставной хондроматоз// Арх. патологии. 2006. № 5. С. 28–30.
41.        Федорова А.В. Cовременные возможности лучевой диагностики хрящеобразующих опухолей скелета. Автореферат. ФГБУ «НМИЦ онкологии им. Н.Н. Блохина», М.: 2019.
42.        Weinberg J., Miller T.T., Handelsman J.E., Kahn L.B., Godfried D.H., Kenan S. Periosteal chondrosarcoma in a 9-year-old girl with osteochondromatosis. Skeletal Radiol 2005, V34, P. 539-542.
43.        Pansuriya T.C., van E.R., d’Adamo P., et al. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat. Genet. 2011. Nov 6; 43(12):1256-1261.
44.        Amary M.F., Bacsi K., Maggiani F., et al. IDH1 and IDH2 mutationsarefrequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J. Pathol 2011,V. 224. P.334-343.
45.        Mosier M.S., Patel T., Strenge K., Mosier A.D. Chondrosarcoma in childchood: radiologic and clinical conundrum. J. Radiol Case Rep 2012, V. 12, #6, P. 32-37.
46.        Robinson P., White L.M., Sundaram M., et al. Periosteal chondroid tumors: Radiologic evaluation with pathologic correlation. Am. J. Roentgenol. 2001; 177:1183-1188.
47.        Meijer D., de Jong D., Pansuriya T.C., et al. Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma. Genes Chromosomes Cancer 2012, V. 51, P. 899-909.
48.        Блудов А.Б. и др. Высокодифференцированная центральная (интрамедуллярная) остеосаркома – рентгенологическое и морфологическое описание двух случаев // Вопросы Онкологии. 2012; 58; №5.
49.        Epithelioid angiosarcoma of the scapula, J. Burk et al., In Vivo Sep 2010, 24(5), 783-786.
50.        Блудов А.Б. и др. Гигантоклеточная опухоль кости // Саркомы костей, мягких тканей и опухоли кожи. 2014. №1. С. 16–34.
51.        Alcalay M. Strategy for identifying primary malignancies with inaugural bone metastases/ Alcalay M., Azais I., Brigeon B. et al.// Revue du Rhumatisme. 1995. № 62(10). P. 632-642.
52.        Tyrrell P. Bone Metastasis 1: Spine/ Tyrrell P., Cassar-Pullichino V., Lalam R., Tins B.// In Davies A., Sundaram M. James S. Imaging of bone tumors and tumor-like lesions. Springer. 2009. Р. 461-462.
53.        Неред А.С. и др. МРТ в диагностике и оценке результатов лечения у больного первичной неходжкинской лимфомой позвоночника // Саркомы костей, мягких тканей и опухоли кожи. 2013. №2. С. 11–17.
54.        Неред А.С. МРТ в диагностике неходжкинских лимфом с поражением позвоночника и компрессией спинного мозга // Клиническая онкогематология. 2013. Т. 6, №4. С. 421–426.
55.        Beal K. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients/ Beal K., Allen L., Yahalom J.// Cancer. 2006. №106. Р. 2652-2656.
56.        Adams H. Primary diffuse large B-cell lymphomas of the bone: prognostic relevance of protein expression and clinical factors/ Adams H., Tzankov A., d’Hondt S. et al.// Hum Pathol. 2008. №39. Р. 1323-1330.